ProfileGDS4516 / 228317_at
TitleColorectal cancer: laser microdissected tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 1 stage: 2a stage: 2b stage: 3a stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM537341 GSM537345 GSM537355 GSM537366 GSM537370 GSM537380 GSM537392 GSM537415 GSM537417 GSM537422 GSM537423 GSM537427 GSM537430 GSM537336 GSM537337 GSM537348 GSM537349 GSM537356 GSM537361 GSM537374 GSM537377 GSM537378 GSM537379 GSM537383 GSM537388 GSM537395 GSM537400 GSM537404 GSM537409 GSM537418 GSM537425 GSM537333 GSM537342 GSM537347 GSM537350 GSM537362 GSM537363 GSM537368 GSM537376 GSM537381 GSM537386 GSM537398 GSM537402 GSM537405 GSM537371 GSM537421 GSM537424 GSM537432 GSM537331 GSM537332 GSM537334 GSM537338 GSM537353 GSM537357 GSM537358 GSM537375 GSM537389 GSM537390 GSM537393 GSM537399 GSM537407 GSM537408 GSM537428 GSM537354 GSM537410 GSM537413 GSM537396 GSM537397 GSM537330 GSM537369 GSM537373 GSM537401 GSM537343 GSM537367 GSM537382 GSM537385 GSM537391 GSM537419 GSM537420 GSM537429 GSM537431 GSM537387 GSM537414 GSM537433 GSM537335 GSM537339 GSM537340 GSM537344 GSM537346 GSM537351 GSM537352 GSM537359 GSM537360 GSM537364 GSM537365 GSM537372 GSM537384 GSM537394 GSM537403 GSM537406 GSM537411 GSM537412 GSM537416 GSM537426 22% 28% 23% 20% 22% 24% 20% 25% 31% 31% 25% 27% 24% 29% 27% 28% 27% 26% 25% 27% 27% 25% 22% 33% 25% 28% 28% 24% 27% 26% 32% 26% 26% 29% 26% 24% 25% 25% 25% 23% 26% 26% 30% 33% 26% 24% 20% 25% 28% 35% 23% 27% 29% 21% 27% 18% 28% 27% 28% 23% 21% 28% 28% 24% 22% 23% 20% 25% 26% 25% 31% 17% 25% 21% 24% 26% 24% 28% 23% 31% 28% 24% 23% 26% 26% 24% 23% 28% 26% 29% 27% 33% 20% 21% 30% 31% 21% 27% 25% 22% 28% 25% 22% 26% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM537341patient 115, cancer, LCM [OPG study]4.0025122
GSM537345patient 119, cancer, LCM [OPG study]4.2393628
GSM537355patient 138, cancer, LCM [OPG study]4.0553223
GSM537366patient 154, cancer, LCM [OPG study]3.917520
GSM537370patient 022, cancer, LCM [OPG study]3.9425222
GSM537380patient 037, cancer, LCM [OPG study]4.0324224
GSM537392patient 077, cancer, LCM [OPG study]3.85620
GSM537415patient 032, cancer, LCM [OPG study]4.0675925
GSM537417patient 042, cancer, LCM [OPG study]4.4893131
GSM537422patient 059, cancer, LCM [OPG study]4.4132431
GSM537423patient 064, cancer, LCM [OPG study]4.0871325
GSM537427patient 084, cancer, LCM [OPG study]4.1450227
GSM537430patient 090, cancer, LCM [OPG study]4.0805324
GSM537336patient 107, cancer, LCM [OPG study]4.2461429
GSM537337patient 108, cancer, LCM [OPG study]4.1457927
GSM537348patient 124, cancer, LCM [OPG study]4.2176328
GSM537349patient 125, cancer, LCM [OPG study]4.2068727
GSM537356patient 139, cancer, LCM [OPG study]4.1653626
GSM537361patient 147, cancer, LCM [OPG study]4.172625
GSM537374patient 026, cancer, LCM [OPG study]4.2152527
GSM537377patient 033, cancer, LCM [OPG study]4.2678627
GSM537378patient 034, cancer, LCM [OPG study]4.0771525
GSM537379patient 036, cancer, LCM [OPG study]3.9939622
GSM537383patient 046, cancer, LCM [OPG study]4.4918733
GSM537388patient 063, cancer, LCM [OPG study]4.1086125
GSM537395patient 082, cancer, LCM [OPG study]4.1883428
GSM537400patient 099, cancer, LCM [OPG study]4.242728
GSM537404patient 129, cancer, LCM [OPG study]4.1350424
GSM537409patient 141, cancer, LCM [OPG study]4.1431627
GSM537418patient 044, cancer, LCM [OPG study]4.1092426
GSM537425patient 070, cancer, LCM [OPG study]4.4359532
GSM537333patient 102, cancer, LCM [OPG study]4.1659826
GSM537342patient 116, cancer, LCM [OPG study]4.1417226
GSM537347patient 123, cancer, LCM [OPG study]4.3529829
GSM537350patient 127, cancer, LCM [OPG study]4.1756326
GSM537362patient 148, cancer, LCM [OPG study]4.0885924
GSM537363patient 150, cancer, LCM [OPG study]4.1138925
GSM537368patient 156, cancer, LCM [OPG study]4.1405325
GSM537376patient 031, cancer, LCM [OPG study]4.1363625
GSM537381patient 038, cancer, LCM [OPG study]4.0332223
GSM537386patient 057, cancer, LCM [OPG study]4.1776626
GSM537398patient 094, cancer, LCM [OPG study]4.1640826
GSM537402patient 109, cancer, LCM [OPG study]4.3597630
GSM537405patient 130, cancer, LCM [OPG study]4.534933
GSM537371patient 023, cancer, LCM [OPG study]4.1375526
GSM537421patient 055, cancer, LCM [OPG study]4.0310824
GSM537424patient 065, cancer, LCM [OPG study]3.8999720
GSM537432patient 097, cancer, LCM [OPG study]4.1135225
GSM537331patient 100, cancer, LCM [OPG study]4.2414828
GSM537332patient 101, cancer, LCM [OPG study]4.5296435
GSM537334patient 103, cancer, LCM [OPG study]4.0308923
GSM537338patient 110, cancer, LCM [OPG study]4.1801727
GSM537353patient 135, cancer, LCM [OPG study]4.270829
GSM537357patient 142, cancer, LCM [OPG study]3.8890121
GSM537358patient 143, cancer, LCM [OPG study]4.1865427
GSM537375patient 030, cancer, LCM [OPG study]3.8332118
GSM537389patient 068, cancer, LCM [OPG study]4.1904528
GSM537390patient 072, cancer, LCM [OPG study]4.1623827
GSM537393patient 078, cancer, LCM [OPG study]4.1923128
GSM537399patient 095, cancer, LCM [OPG study]4.051523
GSM537407patient 133, cancer, LCM [OPG study]3.9761421
GSM537408patient 140, cancer, LCM [OPG study]4.2361328
GSM537428patient 086, cancer, LCM [OPG study]4.2478128
GSM537354patient 136, cancer, LCM [OPG study]4.0448324
GSM537410patient 146, cancer, LCM [OPG study]4.0216722
GSM537413patient 027, cancer, LCM [OPG study]3.9568423
GSM537396patient 083, cancer, LCM [OPG study]3.8941720
GSM537397patient 088, cancer, LCM [OPG study]4.0810425
GSM537330patient 006, cancer, LCM [OPG study]4.1628926
GSM537369patient 015, cancer, LCM [OPG study]4.0891425
GSM537373patient 025, cancer, LCM [OPG study]4.3608331
GSM537401patient 106, cancer, LCM [OPG study]3.7965317
GSM537343patient 117, cancer, LCM [OPG study]4.113425
GSM537367patient 155, cancer, LCM [OPG study]3.9632121
GSM537382patient 041, cancer, LCM [OPG study]4.0638424
GSM537385patient 053, cancer, LCM [OPG study]4.1616626
GSM537391patient 073, cancer, LCM [OPG study]4.0413224
GSM537419patient 045, cancer, LCM [OPG study]4.2520328
GSM537420patient 052, cancer, LCM [OPG study]4.0771523
GSM537429patient 089, cancer, LCM [OPG study]4.2935831
GSM537431patient 096, cancer, LCM [OPG study]4.3335328
GSM537387patient 061, cancer, LCM [OPG study]4.0233724
GSM537414patient 028, cancer, LCM [OPG study]3.9893623
GSM537433patient 098, cancer, LCM [OPG study]4.1719926
GSM537335patient 104, cancer, LCM [OPG study]4.1390426
GSM537339patient 111, cancer, LCM [OPG study]3.9989724
GSM537340patient 113, cancer, LCM [OPG study]4.0342323
GSM537344patient 118, cancer, LCM [OPG study]4.2674628
GSM537346patient 011, cancer, LCM [OPG study]4.120926
GSM537351patient 128, cancer, LCM [OPG study]4.3111629
GSM537352patient 134, cancer, LCM [OPG study]4.1772327
GSM537359patient 144, cancer, LCM [OPG study]4.5305933
GSM537360patient 145, cancer, LCM [OPG study]3.8809720
GSM537364patient 152, cancer, LCM [OPG study]3.9478521
GSM537365patient 153, cancer, LCM [OPG study]4.3483530
GSM537372patient 024, cancer, LCM [OPG study]4.4268931
GSM537384patient 048, cancer, LCM [OPG study]3.9362821
GSM537394patient 081, cancer, LCM [OPG study]4.1844727
GSM537403patient 121, cancer, LCM [OPG study]4.1602225
GSM537406patient 131, cancer, LCM [OPG study]4.0080722
GSM537411patient 149, cancer, LCM [OPG study]4.3349628
GSM537412patient 019, cancer, LCM [OPG study]4.1286925
GSM537416patient 035, cancer, LCM [OPG study]3.942522
GSM537426patient 079, cancer, LCM [OPG study]4.086826